Mesenchymal stromal/stem cells in tumour initiation, progression and therapy

Hass, R. Role of MSC in the tumor microenvironment. Cancers 12, 2107 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, C., Zhao, H. & Wang, B. Mesenchymal stem/stromal cells: developmental origin, tumorigenesis and translational cancer therapeutics. Transl. Oncol. 14, 100948 (2021).

Article  CAS  PubMed  Google Scholar 

Rennert, R. C., Sorkin, M., Garg, R. K. & Gurtner, G. C. Stem cell recruitment after injury: lessons for regenerative medicine. Regen. Med. 7, 833–850 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sordi, V. Mesenchymal stem cell homing capacity. Transplantation 87, S42–S45 (2009).

Article  PubMed  Google Scholar 

Klopp, A. H. et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res. 67, 11687–11695 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kidd, S. et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27, 2614–2623 (2009). This study demonstrates the mobility and adaptability of MSCs to numerous sites in response to various types of injuries.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo, Y.-C., Chiu, Y.-H., Chen, C.-P. & Wang, H.-S. Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration. Stem Cell Res. Ther. 9, 281 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hocking, A. M. The role of chemokines in mesenchymal stem cell homing to wounds. Adv. Wound Care 4, 623–630 (2015).

Article  Google Scholar 

Kucia, M. et al. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner. Arch. Immunol. Ther. Exp. 54, 121–135 (2006).

Article  CAS  Google Scholar 

Ishikawa, M. et al. MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing. PLoS ONE 9, e104954 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Liu, L. et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int. 2013, 435093 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006). This foundational paper defines the minimum criteria needed to isolate and manage MSC primary cell lines.

Article  CAS  PubMed  Google Scholar 

Viswanathan, S. et al. Mesenchymal stem versus stromal cells: international society for cell and gene therapy (ISCT) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy 21, 1019–1024 (2019).

Article  CAS  PubMed  Google Scholar 

Rustad, K. C. & Gurtner, G. C. Mesenchymal stem cells home to sites of injury and inflammation. Adv. Wound Care 1, 147–152 (2012).

Article  Google Scholar 

Zhu, M. et al. Orchestration of mesenchymal stem/stromal cells and inflammation during wound healing. Stem Cells Transl. Med. 12, 576–587 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahangar, P., Mills, S. J. & Cowin, A. J. Mesenchymal stem cell secretome as an emerging cell-free alternative for improving wound repair. Int. J. Mol. Sci. 21, 7038 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, Y. et al. Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J. Cell. Mol. Med. 14, 1494–1508 (2010).

Article  PubMed  Google Scholar 

Hamou, C. et al. Mesenchymal stem cells can participate in ischemic neovascularization. Plast. Reconstr. Surg. 123, 45S–55S (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moustakas, A. & Heldin, C.-H. Mechanisms of TGFβ-Induced epithelial-mesenchymal transition. J. Clin. Med. 5, 63 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Xu, J., Lamouille, S. & Derynck, R. TGF-β-induced epithelial to mesenchymal transition. Cell Res. 19, 156–172 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song, Y. et al. Emerging role of mesenchymal stromal cells in gynecologic cancer therapy. Stem Cell Res. Ther. 14, 347 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Nitzsche, F. et al. Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells 35, 1446–1460 (2017).

Article  PubMed  Google Scholar 

Walewska, A., Janucik, A., Tynecka, M., Moniuszko, M. & Eljaszewicz, A. Mesenchymal stem cells under epigenetic control — the role of epigenetic machinery in fate decision and functional properties. Cell Death Dis. 14, 720 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reinisch, A. et al. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood 125, 249–260 (2015).

Article  CAS  PubMed  Google Scholar 

Kim, M. & Costello, J. DNA methylation: an epigenetic mark of cellular memory. Exp. Mol. Med. 49, e322 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stavely, R. & Nurgali, K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl. Med. 9, 985–1006 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Sai, B. et al. Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs. Cell Death Dis. 10, 941 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mader, E. K. et al. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clin. Cancer Res. 15, 7246–7255 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang, D.-Y. et al. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. Int. J. Cancer 127, 1975–1983 (2010).

Article  CAS  PubMed  Google Scholar 

Mader, E. K. et al. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J. Transl. Med. 11, 20 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, Y., Zhao, J., Jiang, J., Chen, F. & Fang, X. Doxorubicin delivered using nanoparticles camouflaged with mesenchymal stem cell membranes to treat colon cancer. Int. J. Nanomedicine 15, 2873–2884 (2020).

Article  CAS  PubMed 

Comments (0)

No login
gif